Yield10 Bioscience Inc expected to post a loss of 65  cents a share - Earnings Preview

Yield10 Bioscience

10/05/2022 03:04

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 11. 
    * The Woburn Massachusetts-based  company is expected to
report  a
11.7% decrease in revenue to $173 thousand from $196 thousand a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Yield10 Bioscience
Inc is
for a loss of 65 cents per share. For the same quarter last
year, the company reported a loss of 60 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $10.5​, above​ its last closing price
of $2.48. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.64       -0.63      -0.61     Beat    3.9
 Sep. 30 2021  -0.65       -0.65      -0.49     Beat    24.6
 Jun. 30 2021  -0.54       -0.54      -0.64     Missed  -18.5​
 Mar. 31 2021  -0.54       -0.55      -0.60     Missed  -8.1
 ​​Dec.                    -0.70      -0.79     Missed  -13.3
 31 2020                                                
 Sep. 30 2020  -0.95       -0.94      -0.87     Beat    7.9​
 Jun. 30 2020  -1.30       -1.30      -1.09     Beat    16.2
 Mar. 31 2020  -2.13       -1.97      -2.12     Missed  -7.6
 This summary was machine generated May 10 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated